GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Repligen Corp (NAS:RGEN) » Definitions » E10

Repligen (Repligen) E10 : $1.10 (As of Mar. 2024)


View and export this data going back to 1986. Start your Free Trial

What is Repligen E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Repligen's adjusted earnings per share data for the three months ended in Mar. 2024 was $0.040. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $1.10 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Repligen's average E10 Growth Rate was -0.90% per year. During the past 3 years, the average E10 Growth Rate was 32.40% per year. During the past 5 years, the average E10 Growth Rate was 35.10% per year. During the past 10 years, the average E10 Growth Rate was 16.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Repligen was 180.20% per year. The lowest was -3.30% per year. And the median was 17.10% per year.

As of today (2024-05-21), Repligen's current stock price is $169.86. Repligen's E10 for the quarter that ended in Mar. 2024 was $1.10. Repligen's Shiller PE Ratio of today is 154.42.

During the past 13 years, the highest Shiller PE Ratio of Repligen was 538.77. The lowest was 50.73. And the median was 150.87.


Repligen E10 Historical Data

The historical data trend for Repligen's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Repligen E10 Chart

Repligen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.35 0.47 0.73 1.05 1.09

Repligen Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.11 1.14 1.16 1.09 1.10

Competitive Comparison of Repligen's E10

For the Medical Instruments & Supplies subindustry, Repligen's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Repligen's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Repligen's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Repligen's Shiller PE Ratio falls into.



Repligen E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Repligen's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.04/131.7762*131.7762
=0.040

Current CPI (Mar. 2024) = 131.7762.

Repligen Quarterly Data

per share eps CPI Adj_EPS
201406 0.090 100.560 0.118
201409 0.040 100.428 0.052
201412 -0.010 99.070 -0.013
201503 0.090 99.621 0.119
201506 0.110 100.684 0.144
201509 0.080 100.392 0.105
201512 0.010 99.792 0.013
201603 0.050 100.470 0.066
201606 0.110 101.688 0.143
201609 0.030 101.861 0.039
201612 0.150 101.863 0.194
201703 0.090 102.862 0.115
201706 0.240 103.349 0.306
201709 0.110 104.136 0.139
201712 0.270 104.011 0.342
201803 0.080 105.290 0.100
201806 0.060 106.317 0.074
201809 0.100 106.507 0.124
201812 0.120 105.998 0.149
201903 0.170 107.251 0.209
201906 0.170 108.070 0.207
201909 0.030 108.329 0.036
201912 0.070 108.420 0.085
202003 0.180 108.902 0.218
202006 0.300 108.767 0.363
202009 0.270 109.815 0.324
202012 0.360 109.897 0.432
202103 0.520 111.754 0.613
202106 0.640 114.631 0.736
202109 0.580 115.734 0.660
202112 0.500 117.630 0.560
202203 0.810 121.301 0.880
202206 0.880 125.017 0.928
202209 0.710 125.227 0.747
202212 0.850 125.222 0.894
202303 0.510 127.348 0.528
202306 0.350 128.729 0.358
202309 0.320 129.860 0.325
202312 -0.460 129.419 -0.468
202403 0.040 131.776 0.040

Add all the adjusted EPS together and divide 10 will get our e10.


Repligen  (NAS:RGEN) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Repligen's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=169.86/1.1
=154.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Repligen was 538.77. The lowest was 50.73. And the median was 150.87.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Repligen E10 Related Terms

Thank you for viewing the detailed overview of Repligen's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Repligen (Repligen) Business Description

Traded in Other Exchanges
Address
41 Seyon Street, Building 1, Suite 100, Waltham, MA, USA, 02453
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.
Executives
Christine Gebski officer: See Remarks C/O REPLIGEN CORPORATION, 41 SYON ST. BLDG. 1, SUITE 100, WALTHAM MA 02453
Olivier Loeillot officer: President and CCO C/O REPLIGEN CORPORATION, 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM MA 02453
Jason K Garland officer: CFO 10000 WEHRLE DRIVE, CLARENCE NY 14031
Karen A Dawes director 579 BELLEVUE AVE, NEWPORT RI 02840
Martin D Madaus director 290 CONCORD ROAD, BILLERICA MA 01821
Jon Snodgres officer: CFO REPLIGEN CORPORATION, 41 SEYON STREET, BUILDING #1, SUITE 100, WALTHAM MA 02435
Anthony Hunt director, officer: Chief Executive Officer 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM MA 02452
Ralf Kuriyel officer: Senior VP, R&D 41 SEYON ST, BLDG 1, STE. 100, WALTHAM MA 02452
James Bylund officer: SVP, Global Operations & IT C/O REPLIGEN CORPORATION, 41 SYON ST. BLDG. SUITE 100, WALTHAM MA 02453
Konstantin Konstantinov director C/O CODIAK BIOSCIENCES, INC., 500 TECHNOLOGY SQUARE, 9TH FLOOR, CAMBRIDGE MA 02139
Manner Carrie Eglinton director C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094
Ryan Thomas F Jr director
Nicolas Barthelemy director 1750 BELLA LAGUNA CT, ENCINITAS CA 92024
John Cox director C/O BIOVERATIV INC., 225 SECOND AVENUE, WALTHAM MA 02451
Rohin Mhatre director C/O REPLIGEN CORP., 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM MA 02453